RG7-33811-65820
4 vaccinations
5 coded responses
38 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 604 / IL
- Registered
- 2021-08-19
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-29
Dose 1 — Pfizer-BioNTech
-
2021-08-19
Registered in v-safe
-
2021-08-19
Dose 2 — Pfizer-BioNTech
- 2021-08-20
- 2021-08-21
- 2021-08-22
- 2021-08-23
- 2021-08-24
- 2021-08-25
- 2021-08-26
- 2021-09-02
- 2021-09-09
- 2021-09-16
- 2021-09-24
- 2021-09-30
- 2021-11-20
-
2022-02-18
Dose 3 — Moderna
- 2022-02-18
- 2022-02-18
- 2022-02-20
-
2022-02-22
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · HeadacheFree text: Swollen axial lymph nodeMedDRA releases: 2024-11 · check-in free text available
-
2022-02-23
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Swollen axial lymph nodeMedDRA releases: 2024-11 · check-in free text available
- 2022-02-24
- 2022-02-25
- 2022-03-05
- 2022-03-13
- 2022-03-21
- 2022-03-27
- 2022-04-02
-
2022-05-20
Survey response — 3 months, dose 3MedDRA: Pyrexia — Feeling: FairFree text: FeverMedDRA releases: 2024-11 · check-in free text available
-
2022-08-21
Survey response — 6 months, dose 3MedDRA: Anosmia, COVID-19, Pyrexia — Feeling: GoodFree text: COVID Fever loss of smellMedDRA releases: 2024-11 · check-in free text available
-
2022-11-03
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-11-05
- 2022-11-07
- 2022-11-09
- 2022-11-10
- 2022-11-17
- 2022-11-24
-
2022-12-01
Survey response — day 28, dose 4MedDRA: Dizziness, Fatigue, Headache, Vision blurred — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Blurry vision, headaches, dizziness , fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-12-09
- 2022-12-16
- 2023-02-04
- 2023-05-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-29 | Pfizer-BioNTech | No |
| 2 | 2021-08-19 | Pfizer-BioNTech | No |
| 3 | 2022-02-18 | Moderna | No |
| 4 | 2022-11-03 | Pfizer-BioNTech | Flu |
Free text
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen axial lymph node
Systemic reaction (other): Swollen axial lymph node
Release 11 — 3 months, dose 3
Symptoms: Fever
Release 12 — 6 months, dose 3
Symptoms: COVID Fever loss of smell
Release 12 — day 28, dose 4
Symptoms: Blurry vision, headaches, dizziness , fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Vision blurred | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release